Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  AstraZeneca PLC    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 2017 2018 2019 2020 (e) 2021 (e) 2022 (e)
Sales 22 465 22 090 24 384 27 106 29 878 33 170
EBITDA 6 713 7 140 6 686 8 321 10 002 12 206
Operating profit (EBIT) 6 855 5 672 6 436 7 449 9 189 11 522
Pre-Tax Profit (EBT) 2 227 1 993 1 548 3 773 6 295 8 509
Net income 3 001 2 155 1 335 3 013 4 958 6 459
P/E ratio 29,2x 44,0x 97,9x 39,0x 27,8x 20,4x
EPS ( $ ) 2,37 1,70 1,03 2,47 3,46 4,73
Dividend per Share ( $ ) 2,80 2,80 2,80 2,85 2,91 2,92
Yield 4,05% 3,74% 2,78% 2,96% 3,02% 3,03%
Reference price ( $ ) 69,123 74,881 100,869 96,239 96,239 96,239
Announcement Date 02/02/2018
07:00am
02/14/2019
07:00am
02/14/2020
07:01am
- - -
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 2017 2018 2019 2020 (e) 2021 (e) 2022 (e)
Debt 14 483 14 282 12 009 13 206 11 790 11 144
Finance - - - - - -
Operating income (EBITDA) 6 713 7 140 6 686 8 321 10 002 12 206
Leverage
(Debt/EBITDA)
2,16x 2,00x 1,80x 1,59x 1,18x 0,91x
Capital Expenditure 1 326 1 043 979 1 214 1 260 1 336
Free Cash Flow (FCF) 2 252 1 575 1 990 4 285 5 395 7 334
Book Value Per Share (BVPS) ( $ ) 11,8 9,84 10,1 10,9 12,4 14,1
Cash Flow per Share ( $ ) 2,82 2,07 2,28 4,58 5,76 7,15
Announcement Date 02/02/2018
07:00am
02/14/2019
07:00am
02/14/2020
07:01am
- - -
Balance Sheet Analysis
Assessed data source
© 2020 S&P Global Market Intelligence
Financial Ratios

Size 2020e 2021e
Capitalization 126 283 M $ -
Entreprise Value (EV) 139 490 M $ 138 073 M $
Valuation 2020e 2021e
P/E ratio (Price / EPS) 39,0x 27,8x
Capitalization / Revenue 4,66x 4,23x
EV / Revenue 5,15x 4,67x
EV / EBITDA 16,8x 13,9x
Yield (DPS / Price) 2,96% 3,02%
Price to book (Price / BVPS) 8,82x 7,76x
Profitability 2020e 2021e
Operating Margin (EBIT / Sales) 27,5% 30,8%
Operating Leverage (Delta EBIT / Delta Sales) 1,41x 2,28x
Net Margin (Net Profit / Revenue) 11,1% 16,6%
ROA (Net Profit / Asset) 5,20% 10,0%
ROE (Net Profit / Equities) 36,7% 42,6%
Rate of Dividend 115% 84,2%
Balance Sheet Analysis 2020e 2021e
CAPEX / Sales   4,48% 4,22%
Cash Flow / Sales 22,2% 25,3%
Capital Intensity (Assets / Sales) 2,14x 1,66x
Financial Leverage (Net Debt / EBITDA) 1,59x 1,18x
EPS & Dividend